Clinical outcome of amrubicin therapy according to the prior chemotherapy sensitivities of extensive small cell lung cancer.

Osaka city medical journal

Volumn 57, Issue 2, 2011, Pages 59-66

  Mitsuoka, Shigeki ^a   Kudoh, Shinzoh ^b   Kimura, Tatsuo ^b   Yoshimura, Naruo ^b   Tanaka, Hidenori ^b   Suzumura, Tomohiro ^b   Umekawa, Kanako ^b   Nagata, Misato ^b   Ueda, Takako ^b   Hirata, Kazuto ^b  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMRUBICIN; ANTHRACYCLINE; ANTINEOPLASTIC AGENT;

AGED; ARTICLE; DRUG RESISTANCE; FEMALE; HUMAN; KAPLAN MEIER METHOD; LUNG SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SALVAGE THERAPY; SURVIVAL RATE; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; AGED, 80 AND OVER; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SMALL CELL LUNG CARCINOMA; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84859507328     PISSN: 00306096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)